Contribute Try STAT+ Today

Teladoc is teeing itself up to remain a dominant digital health provider long after the worst of the pandemic subsides.

The telehealth giant, like many other virtual care companies, has seen its business boom with the flood of patients turning to virtual appointments as the crisis continues. In a post-pandemic world, though, Teladoc will face challenges as in-person clinics and hospitals reopen their doors and virtual care is no longer the only means of getting health care. To capitalize on its success and grow its member base ahead of time, the company is adding new high-profile clients, increasing its average deal size, and selling itself as a one-stop shop for multiple health needs.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED

What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.